In summary, the data presented in this study suggest that IGF-1R inhibition induced by lentivirus-mediated RNAi can significantly suppress HCC growth and invasion at least in part through down-regulating midkine expression, and IGF-1R is a promising target for HCC gene therapy. This evidence concerns the gene IGF1R and hepatocellular carcinoma.